Search

everythinglearnresearchcommunity

for

Search:↓

Betulinic acid can help treat hepatitis C by stopping virus replication.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.